|
Report Date : |
07.03.2012 |
IDENTIFICATION DETAILS
|
Name : |
LABORATORIO QUIM-FAR, C.A. |
|
|
|
|
Registered Office : |
Calle Chacaito, Quinta Nueva Eegovia, Urb. Bello Monte Caracas |
|
|
|
|
Country : |
Venezuela |
|
|
|
|
Financials (as on) : |
31.10.2009 |
|
|
|
|
Date of Incorporation : |
04.10.1976 |
|
|
|
|
Com. Reg. No.: |
Public Registry No. 35, Vol. 124-A., File 41.679 |
|
|
|
|
Legal Form : |
Stock Company |
|
|
|
|
Line of Business : |
Production and sale of pharmaceutical and chemical products: analgesics, antibiotics, antifungal, vitamins, nasal, cardiovascular, antihistamine, antiemetic medicnes, among others. |
|
|
|
|
No. of Employees : |
19 approximately |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Moderate |
|
Payment Behaviour : |
Unknown |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
Venezuela |
B2 |
B2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
IDENTIFICATION
|
|||||||||||||||||
|
CORRECT COMPANY NAME |
LABORATORIO
QUIM-FAR, C.A. |
||||||||||||||||
|
TAXPAYER REGISTRATION |
RIF J-00113498-0 |
||||||||||||||||
|
MAIN ADDRESS |
Calle Chacaito, Quinta Nueva Eegovia, Urb.
Bello Monte |
||||||||||||||||
|
PROVINCE / DEPARTAMENT |
Caracas |
||||||||||||||||
|
STATE / REGION |
Caracas |
||||||||||||||||
|
COUNTRY |
VENEZUELA |
||||||||||||||||
|
TELEPHONE |
(58212) 9511684 / 9536416 |
||||||||||||||||
|
E-MAIL |
|||||||||||||||||
|
WEB |
|||||||||||||||||
|
|
|||||||||||||||||
|
|||||||||||||||||
|
|
|||||||||||||||||
LEGAL BACKGROUNDS
|
|
|
LEGAL STATUS |
Stock Company |
|
DATE OF INCORPORATION |
04OCT1976 |
|
PLACE OF REGISTRY |
Caracas (Registry of Companies IV) |
|
DURATION |
50 years |
|
REGISTRATION |
Public Registry No. 35, Vol. 124-A., File
41.679 |
|
INITIAL CAPITAL |
Bs. 100,000.= |
|
CURRENT PAID-IN CAPITAL |
Bs. 260,000.= (paid-in) |
|
LAST CAPITAL INCREASE |
14/11/2007 |
|
CLASS OF SHARES |
Registered |
|
SHARE VALUE |
Bs. 1.00 |
|
CURRENT EXCHANGE RATE (US$) |
Bs. 4,30 per 1 USD |
|
COMMENTS |
Subject Company was originally registered as a Limited Liability Company (SRL). In 1991, its legal status was changed to Corporation (C.A.)The Board of Directors was elected on September 17, 2007 until 2012. Shareholders' equity: 1,245,921.= |
DIRECTORS - EXECUTIVES – SHAREHOLDERS
|
|||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||
WHO IS WHO?
|
|
|
MASIRONI PERERA,
LUIS AMBROSIO NELSON |
|
|
NATIONALITY |
Venezuelan |
|
D.O.B. |
1961 |
|
ID |
CI 5313499 |
|
|
|
|
|
|
|
MASIRONI
GONFIANTINI, NELSON |
|
|
|
|
|
|
|
|
MASIRONI PERERA,
CARMEN ELENA |
|
|
NATIONALITY |
Venezuelan |
|
D.O.B. |
1955 |
|
ID |
CI 4355487 |
|
|
|
|
|
|
|
PERERA DE
MASIRONI, CARMEN |
|
|
|
|
|
|
|
|
MASIRONI PERERA,
DARCY VERONICA |
|
|
NATIONALITY |
Venezuelan |
|
D.O.B. |
1956 |
|
ID |
CI 4766689 |
|
|
|
|
|
|
|
MASIRONI PERERA,
MARIA ZULEIKA |
|
|
NATIONALITY |
Venezuelan |
|
D.O.B. |
1957 |
|
ID |
CI 5532628 |
|
|
|
|
|
|
|
MASIRONI DE
SANTAMARIA, SONIA REGINA |
|
|
NATIONALITY |
Venezuelan |
|
ID |
CI 5532595 |
BUSINESS HISTORY
|
|
The company's founders were NELSON MASIRONI GONFIANTINI, CARMEN PERERA DE MASIRONI and CARMEN ELENA MASIRONI PERERA. |
|
BUSINESS
|
|||||||||
|
Main activity |
Production and sale of pharmaceutical and chemical products: analgesics, antibiotics, antifungal, vitamins, nasal, cardiovascular, antihistamine, antiemetic medicnes, among others. |
||||||||
|
SELLING TerritorY |
Domestic market |
||||||||
|
EMPLOYEES |
19 approximately |
||||||||
|
|||||||||
|
Comments |
WholesalerSubject's sales are aimed at the public and private sector.Its clients include the Ministry of Health, Droguería los Andes, Prosalud, Dronaca, Inquifave, etc.
|
||||||||
FINANCIAL INFORMATION
|
|
|
Interviewee(s) |
Luis Masironi Perera |
|
Position(s) |
President |
|
Disposition |
Excellent.- Full information and updated
figures. |
|
Information provided |
We spoke with Luis Masironi Perera, the company's President, who refused to cooperate with our investigation. Therefore, this report has been prepared through third-party sources where we could obtained the Balance Sheet as of 31/10/2009, fiscal year-end, expressed in Bolivares Fuertes, which is shown below: |
|
Comments |
DATE OF BALANCE SHEET : 31OCT2009 TYPE OF BALANCE SHEET : Historical BALANCE SHEET OF : Year-end CURRENCY : Bs. Fuerte EXCHANGE RATE PER US$ : 4,30 ASSETS CASH AND DEPOSITS : 1.948.292,00 RECEIVABLE : 204.953,00 INVENTORY : 32.170,00 OTHER : 192.879,00 TOTAL CURRENT : 2.378.294,00 FIXED ASSETS : 199.052,00 OTHERS : 129,00 TOTAL ASSETS : 2.577.475,00 LIABILITIES BANKS/SUPPLIERS : 797.502,00 OTHERS : 177.451,00 TOTAL CURRENT : 974.953,00 LONG-TERM : 356.601,00 SHAREHOLDERS' EQUITY : CAPITAL : 260.000,00 RESERVES : 26.000,00 PROFIT (LOSS) : 959.921,00 TOTAL S. EQUITY : 1.245.921,00 TOTAL LIABILITIES/S. EQUITY: 2.577.475,00 SALES : 4.586.692,00 PROFIT (LOSS) : 454.585,00 RATIOS LIQUIDITY RATIO : 2,44 (Current Assets/Current Liabilities) INDEBTEDNESS RATIO : 127,79% (Shareholders' equity/Current Liabilities %) PROFITABILITY RATIO : 9,91% (Profit/Sales %) WORKING CAPITAL : 1.403.341,00 (Current Assets - Current Liabilities) |
|
|
|
|
|
|
|
SALES |
US$ 1,066,672.56 (31OCT2009) |
|
Insurance Comments |
No insurance-related information could be obtained. |
PAYMENTS RECORD: TRADE
REFERENCES
(Confidential
Information) |
|
|
CREDIT HISTORY As the names of Subject's suppliers were not revealed, we could not obtain any trade references. Therefore, the Subject's payment history cannot be accurately determined, but payments are believed to be prompt. |
|
BANKING INFORMATION
|
||||
|
|
|||
|
The names of the banks with which Subject
works were not revealed. |
|
|||
|
|
|||
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.50.03 |
|
|
1 |
Rs.79.32 |
|
Euro |
1 |
Rs.66.02 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.